Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CAPR✓SelectedUSD · CAPRGSK vs CAPR performance historyLatest closeAs of-1.93%09/04
Stock and ETF performance explorer

GSK vs CAPR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+128.6%
CAPR return
-99.1%
Excess return
+227.7%
Maximum drawdown
-49.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioCAPRExcessAlpha
1D-1.9%+1.3%-3.2%-1.9%
7D-1.8%-2.0%+0.2%-1.8%
30D-2.2%+139.2%-141.4%-3.0%
3M-1.8%-66.4%+64.6%-1.5%
6M-10.6%-63.1%+52.5%-10.5%
YTD+4.4%-67.4%+71.9%+4.7%
1Y+30.4%+58.2%-27.8%+26.9%
3Y+60.1%+42.2%+17.9%+54.6%
5Y+46.8%+87.3%-40.5%+40.9%
10Y+79.2%-75.3%+154.5%+68.5%
All+128.6%-99.1%+227.7%+102.9%

Cumulative growth

Daily Returns

Daily percentage return beside CAPR.

Daily Out/Under-Performance

Portfolio return minus CAPR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CAPR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded CAPR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling